{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:38:55Z","timestamp":1793597935627,"version":"4.5.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":1527,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypertension, especially if poorly controlled, is a key determinant of chronic kidney disease (CKD) development and progression to end stage renal disease (ESRD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To assess hypertension and risk factor management, and determinants of systolic blood pressure control in individuals with CKD and hypertension.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design and setting<\/jats:title>\n                    <jats:p>Cross-sectional survey using primary care electronic health records from 47\/49 general practice\u00a0clinics in South London.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Known effective interventions, management of hypertension and cardiovascular disease (CVD) risk in patients with CKD Stages 3\u20135 were\u00a0investigated. Multivariable logistic regression analysis examined the association of demographic factors, comorbidities, deprivation, and CKD coding, with systolic blood pressure\u00a0control status as outcome. Individuals with diabetes were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Adults with CKD Stages 3\u20135 and hypertension represented 4131\/286,162 (1.4%) of the total population; 1984 (48%) of these individuals had undiagnosed CKD without a recorded CKD clinical code. Hypertension was undiagnosed in 25% of the total Lambeth population, and in patients with CKD without diagnosed hypertension, 23.0% had systolic blood pressure &amp;gt;\u2009140\u00a0mmHg compared with 39.8% hypertensives, p\u2009&amp;lt;\u20090.001. Multivariable logistic regression revealed that factors associated with improved systolic blood pressure control in CKD included diastolic blood pressure control, serious mental illness, history of cardiovascular co-morbidities, CKD diagnostic coding, and age\u2009&amp;lt;\u200960\u00a0years. African ethnicity and obesity were associated with poorer systolic blood pressure\u00a0control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We found both underdiagnosed CKD and underdiagnosed hypertension in patients\u00a0with CKD. The poor systolic blood pressure\u00a0control in older age groups\u2009\u2265\u200960\u00a0years and in Black African or obese individuals is clinically important as these groups are at increased risk of mortality\u00a0for cardiovascular diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphic abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s40620-021-01149-0","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T23:35:11Z","timestamp":1637019311000},"page":"901-910","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Hypertension and cardiovascular\u00a0risk factor management in a\u00a0multi-ethnic cohort of\u00a0adults with CKD: a cross sectional study in general practice"],"prefix":"10.1093","volume":"35","author":[{"given":"Edianne Monique","family":"Carpio","sequence":"first","affiliation":[{"name":"Department of Population Health Sciences, King\u2019s College London, London, England 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ashworth","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, King\u2019s College London, London, England 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Asgari","sequence":"additional","affiliation":[{"name":"Renal Department, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, England 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"Shaw","sequence":"additional","affiliation":[{"name":"Renal Department, King\u2019s College Hospital, London, England 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Schartau","sequence":"additional","affiliation":[{"name":"Department of Primary Care & Population Health, Institute of Epidemiology & Health, University College London, London, England 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stevo","family":"Durbaba","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, King\u2019s College London, London, England 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Nitsch","sequence":"additional","affiliation":[{"name":"Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, England 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Molokhia","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, King\u2019s College London, London, England 1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"2026012108030031200_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","article-title":"Chronic kidney disease","volume":"379","author":"Levey","year":"2012","journal-title":"The Lancet"},{"key":"2026012108030031200_CR2","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic Kidney Disease","volume":"389","author":"Webster","year":"2017","journal-title":"The Lancet"},{"key":"2026012108030031200_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/ndt\/gfy330 30418646","article-title":"Too much nephrology? The CKD epidemic is real and concerning. A PRO view","volume":"34","author":"Gansevoort","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2026012108030031200_CR4"},{"key":"2026012108030031200_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207960 30475893","article-title":"Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England","volume":"13","author":"Nguyen","year":"2018","journal-title":"PLoS ONE"},{"key":"2026012108030031200_CR6"},{"key":"2026012108030031200_CR7"},{"key":"2026012108030031200_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jdiacomp.2017.12.003 29352693","article-title":"The association between estimated glomerular filtration rate, albuminuria, and risk of cardiovascular hospitalizations and all-cause mortality among patients with type 2 diabetes","volume":"32","author":"Nichols","year":"2018","journal-title":"J Diabetes Complications"},{"key":"2026012108030031200_CR9"},{"key":"2026012108030031200_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2369-12-41 21896189","article-title":"The relationship of ethnicity to the prevalence and management of hypertension and associated chronic kidney disease","volume":"12","author":"Hull","year":"2011","journal-title":"BMC Nephrol"},{"key":"2026012108030031200_CR11","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3949\/ccjm.79a.11109 23027732","article-title":"Hypertensive chronic kidney disease in African Americans: strategies for improving care","volume":"79","author":"Martins","year":"2012","journal-title":"Cleve Clin J Med"},{"key":"2026012108030031200_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/ndt\/gfp534 19889870","article-title":"Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension","volume":"25","author":"Hanratty","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2026012108030031200_CR13"},{"key":"2026012108030031200_CR14"},{"key":"2026012108030031200_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1471-2296-14-88 23800117","article-title":"Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care","volume":"14","author":"Fraser","year":"2013","journal-title":"BMC Fam Pract"},{"key":"2026012108030031200_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jama.2010.39 20124537","article-title":"Relation between kidney function, proteinuria, and adverse outcomes","volume":"303","author":"Hemmelgarn","year":"2010","journal-title":"JAMA"},{"key":"2026012108030031200_CR17","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1681\/ASN.2008070730 19357254","article-title":"Combining GFR and Albuminuria to Classify CKD Improves Prediction of ESRD","volume":"20","author":"Hallan","year":"2009","journal-title":"J Am Soc Nephrol JASN"},{"key":"2026012108030031200_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5527\/wjn.v4.i1.57 25664247","article-title":"Biomarkers in chronic kidney disease, from kidney function to kidney damage","volume":"4","author":"Lopez-Giacoman","year":"2015","journal-title":"World J Nephrol"},{"key":"2026012108030031200_CR19","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/ajh.2012.48 22573012","article-title":"Blood Pressure Indexes and End-Stage Renal Disease Risk in Adults With Chronic Kidney Disease","volume":"25","author":"Bell","year":"2012","journal-title":"Am J Hypertens"},{"key":"2026012108030031200_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJM199601043340103 7494564","article-title":"Blood pressure and end-stage renal disease in men","volume":"334","author":"Klag","year":"1996","journal-title":"N Engl J Med"},{"key":"2026012108030031200_CR21","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1097\/01.ASN.0000031805.09178.37 12397049","article-title":"Blood Pressure and Decline in Kidney Function: Findings from the Systolic Hypertension in the Elderly Program (SHEP)","volume":"13","author":"Young","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2026012108030031200_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k5301 30630856","article-title":"Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium","author":"Chang","year":"2019","journal-title":"BMJ"},{"key":"2026012108030031200_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003013 27977587","article-title":"Risk factors for development and progression of chronic kidney disease","author":"Tsai","year":"2016","journal-title":"Medicine"},{"key":"2026012108030031200_CR24","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.dsx.2018.11.014","article-title":"Albuminuric and non-albuminuric patterns of chronic kidney disease in type 2 diabetes","volume":"13","author":"Klimontov","year":"2019","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"2026012108030031200_CR25"},{"key":"2026012108030031200_CR26"},{"key":"2026012108030031200_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/wps.20420 28498599","article-title":"Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls","volume":"16","author":"Correll","year":"2017","journal-title":"World Psychiatry"},{"key":"2026012108030031200_CR28","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1093\/ndt\/gfx280 29045728","article-title":"How do primary care doctors in England and Wales code and manage people with chronic kidney disease? Results from the National Chronic Kidney Disease Audit","volume":"33","author":"Kim","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2026012108030031200_CR29","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clin Trials Lond Engl"},{"key":"2026012108030031200_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000446122 27161620","article-title":"Cardiovascular outcomes in action to control cardiovascular risk in diabetes: impact of blood pressure level and presence of kidney disease","volume":"43","author":"Papademetriou","year":"2016","journal-title":"Am J Nephrol"},{"key":"2026012108030031200_CR31","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/HYPERTENSIONAHA.119.14659","article-title":"Initial Estimated Glomerular Filtration Rate Decline and Long-Term Renal Function During Intensive Antihypertensive Therapy","volume":"75","author":"Collard","year":"2020","journal-title":"Hypertens Dallas Tex"},{"key":"2026012108030031200_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/ndt\/gfv346 26429974","article-title":"Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor\/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial","volume":"31","author":"Bhandari","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2026012108030031200_CR33"},{"key":"2026012108030031200_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrneph.2017.181 29355169","article-title":"Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease","volume":"14","author":"Carrero","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"2026012108030031200_CR35","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.3399\/bjgp19X704105 31160369","article-title":"Improving coding and primary care management for patients with chronic kidney disease: an observational controlled study in East London","volume":"69","author":"Hull","year":"2019","journal-title":"Br J Gen Pract"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-021-01149-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-021-01149-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/35\/3\/901\/66018960\/joneph_35_3_1149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-021-01149-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/35\/3\/901\/66018960\/joneph_35_3_1149.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T13:03:07Z","timestamp":1769000587000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/35\/3\/901\/8325829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,11,16]]},"published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1007\/s40620-021-01149-0","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2021,11,16]]},"assertion":[{"value":"17 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval for LDN was provided by The Lambeth DataNet Steering Group, a sub-group of Lambeth CCG. Information Governance (IG) was approved by the IG team at the Commissioning Support Unit and Lambeth CCG\u2019s Caldicott Guardian.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}